Led by industry thought leaders, we are pioneering the German cannabis market. Our management experts bring 200+ years of experience along the value chain.
.png)
Lars is a profound serial entrepreneur with over 10 years experience in building sustainable companies. Lars is the founder & CEO of SynBiotic SE and has been leading the vision & strategy of the group for over 2 years.
As one of Germany's leading experts, he is appreciated for his in-depth industry know-how from seed to shelf, genetics, extraction methods & analytics such as product development. He is active in the cannabinoid business since 2015.
Daniel Kruse, a hemp industry pioneer for 26 years, is founder and managing director of Hempro International GmbH & Co. KG and HempConsult GmbH, two of Europe's leading hemp companies. Kruse has more than 16 years of experience in hemp food production.
Rainer Seiler has many years of leadership experience, including as Managing Director (Zur Rose Gruppe), as General Sales Manager (ratiopharm) and as Director Key Account Management within the pharmaceutical Industry (Rx, OTC, Gx), as well as with wholesalers and mail-order-pharmacy-companies.
Dr. Thomas Haffner has more than 20 years of experience in the pharmaceutical industry, especially in the areas of product development and product-related licensing business - both nationally and internationally. He is a leading expert on the conception of OTC drugs, project marketing and the licensing business.
Ralf Klesy is an acknowledged marketing and sales consultant with pharmaceutical expertise of more than 20 years. As a consultant and service provider for marketing services, he worked for Boehringer Ingelheim, Berlin Chemie, Merck, Dr. Karl Thomae, among others. Experienced in the structure and set-up of sales processes and units.
Markus Zitzmann-Schreiner is the Sales Director for SynBiotic Sales GmbH. With an experience of 17 years in the pharmaceutical industy, from that 10 years in pain management and 4 years in medical cannabis my mission is to innovate Cannabis therapy.
Dr. Manoukian was a Senior Scientist and Professor at the Ontario Cancer Institute, Princess Margaret Hospital in Toronto for 18 years where he collaborated with multiple Pharma companies such as Celgene, Amgen, and BioTheryX. Since 2017, he leads the NeuroTheryX research platform.
Johannes Gallois is founder of SynBiotic Distribution (formerly GECA Pharma GmbH), one of the first medical cannabis distributors in Germany. He has more than 12 years of leadership, retail and sales experience in international markets for FMCG, lifestyle and healthcare products.
Joscha Krauss is the managing director of MH medical hemp GmbH. He holds a M.Sc. in ecology and is a MasterClass graduate at Dutch medicinal cannabis producer Bedrocan. He is now on the board of the Brussel based association “Medicinal Cannabis Europe“ and the German Cannabis trade association (BvcW).
Rafael Dulon is one of the best-known experts in industrial hemp cultivation in Europe. Since 1997 he has been operating the contract cultivation of industrial hemp with farmers and cooperatives. Rafael Dulon is the founder and managing director of the Germany-based HANF FARM GmbH.
.png)
Bruce Linton is the Founder and former CEO and Chairman of Canopy Growth Corporation, one of the world's largest Cannabis-focused corporations. Bruce currently holds positions on the Board of Creso Pharma, Co-Chairman and former CEO of Martello Technologies Group Inc., and Chairman of the Advisory Board for Red Light Holland Corp. He is an Advisor with Celadon Pharmaceuticals and Above Foods.
.png)
As a serial entrepreneur his strength lies in strategy, operations and in coaching senior leadership, with particular expertise in post-merger-integration and capital market fitness. Sebastian has a master’s degree in business administration with a focus on IT supported marketing and human resources.
Thomas Hanke has extensive transaction experience (private equity, venture capital, growth capital & PIPE transactions) and has, in addition to his work as an investor, also carried out various operational interim mandates within the scope of portfolio management.
Dr. Marlon Braumann is a Serial Entrepreneur and one of the founding partners of the European VC fund Elevat3 Capital – an investment fund mainly focused on biotech, medtech, and fintech investments. Apart from that, Mr. Braumann is the founder of the global wildlife trust AMES Foundation.
Christian Angermayer is the founder of Apeiron Investment Group, his own family office focusing on biotech, fintech and deep tech. Among many other companies, Christian has founded ATAI Life Sciences AG. It has reached approx. USD 1bn valuation within 2.5 years since foundation.
Michael Auerbach is the general partner and founder of the investment holding Subversive Capital. He is also Chairman of the Californian cannabis platform company Parent Company. Previously he was Director of Tilray. Michael is appreciated as one of the most renowned investors in Cannabis companies worldwide.
Lorem Ipsum Lorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem
Lorem Ipsum Lorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Suspendisse varius enim in eros elementum tristique.
